HIM
RMD icon

Hutchens Investment Management’s ResMed RMD Stock Holding History

Hutchens Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-25
Closed -$1K – 139
2014
Q4 		$1K Buy
+25
New +$1.3K ﹤0.01% 197

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hutchens Investment Management's RMD Position: Q1 2015 in Review

Hutchens Investment Management sold out of ResMed (RMD) in Q1 2015, closing a stake of 25 shares — an estimated $1K sold.

Hutchens Investment Management first reported a position in RMD in Q4 2014 and held it in 1 quarter. The position peaked at $1K in Q4 2014. 325 funds tracked by Wall St. Rank hold RMD as of Q1 2015.

  • Hutchens Investment Management reported no remaining ResMed position as of Q1 2015 after selling out during the quarter.
  • Hutchens Investment Management sold 25 ResMed shares in Q1 2015, an estimated $1K.
  • Hutchens Investment Management first reported a position in ResMed in Q4 2014 and held it in 1 quarter.
  • Hutchens Investment Management's ResMed position peaked at $1K in Q4 2014.
  • 325 funds tracked by Wall St. Rank held ResMed as of Q1 2015.

Based on Hutchens Investment Management's 13F filing for Q1 2015, filed 15 May 2015.